CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells.

MLA

Krige, David, et al. “CHR-2797: An Antiproliferative Aminopeptidase Inhibitor That Leads to Amino Acid Deprivation in Human Leukemic Cells.” Cancer Research, vol. 68, no. 16, Aug. 2008, pp. 6669–79. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-07-6627.

APA

Krige, D., Needham, L. A., Bawden, L. J., Flores, N., Farmer, H., Miles, L. E. C., Stone, E., Callaghan, J., Chandler, S., Clark, V. L., Kirwin-Jones, P., Legris, V., Owen, J., Patel, T., Wood, S., Box, G., Laber, D., Odedra, R., Wright, A., … Drummond, A. H. (2008). CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells. Cancer Research, 68(16), 6669–6679. https://doi.org/10.1158/0008-5472.CAN-07-6627

Chicago

Krige, David, Lindsey A Needham, Lindsay J Bawden, Nicolas Flores, Hannah Farmer, Lauren E C Miles, Erica Stone, et al. 2008. “CHR-2797: An Antiproliferative Aminopeptidase Inhibitor That Leads to Amino Acid Deprivation in Human Leukemic Cells.” Cancer Research 68 (16): 6669–79. doi:10.1158/0008-5472.CAN-07-6627.